EWT vs XBI
iShares MSCI Taiwan ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.59% for EWT.
- • EWT pays a higher dividend yield (0.98%).
Side-by-side metrics
| Metric | EWT | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.59% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.98% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $11.05B | $10.92B |
YTD return | 50.56% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.35 | 1.01 |
P/E ratio | 26.95 | — |
Last price | $100.50 | $156.41 |
Inception | — | — |
Issuer | iShares | State Street |
EWT top holdings
| 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 22.32% |
| 2454.TW | MediaTek Inc | 6.10% |
| 2317.TW | Hon Hai Precision Industry Co Ltd | 3.36% |
| 3711.TW | ASE Technology Holding Co Ltd | 3.00% |
| 2308.TW | Delta Electronics Inc | 2.95% |
| 1303.TW | Nan Ya Plastics Corp | 2.58% |
| 3037.TW | Unimicron Technology Corp | 1.95% |
| 2881.TW | Fubon Financial Holdings Co Ltd | 1.91% |
| 2383.TW | Elite Material Co Ltd | 1.89% |
| 2891.TW | CTBC Financial Holding Co Ltd | 1.75% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About EWT
EWT (iShares MSCI Taiwan ETF) is Taiwanese large- and mid-cap equities. Managed by iShares, the fund carries $11.1B in assets under management, an expense ratio of 0.59%, a dividend yield of 0.98%. Its largest holding is Taiwan Semiconductor Manufacturing Co Ltd (2330.TW), which represents 22.3% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 2.0%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.